Yang et al. Trials (2016) 17:470 DOI 10.1186/s13063-016-1588-6
STUDY PROTOCOL
Open Access
Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial Wenying Yang1*, Zhaojun Yang1, Jing Zhao2, Hai Lu2 and Tianhong Luo2
Abstract Background: A large proportion of patients with T2DM in China do not meet accepted HbA1c targets despite the availability of guidelines that describe a treatment pathway for achieving glycemic control. The aim of this study is to identify the fasting plasma glucose (FPG) target that will provide the highest control rate of HbA1c
STUDY PROTOCOL
Open Access
Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial Wenying Yang1*, Zhaojun Yang1, Jing Zhao2, Hai Lu2 and Tianhong Luo2
Abstract Background: A large proportion of patients with T2DM in China do not meet accepted HbA1c targets despite the availability of guidelines that describe a treatment pathway for achieving glycemic control. The aim of this study is to identify the fasting plasma glucose (FPG) target that will provide the highest control rate of HbA1c
